Tissue Localization of Nerve Growth Factor Receptors: Trk A and Low-Affinity Nerve Growth Factor Receptor in Neuroblastoma, Pheochromocytoma, and Retinoblastoma

Overview

Journal Endocr Pathol

Specialties Endocrinology
Pathology

Date 1996 Jan 1

PMID 12114799

Authors

Noriko Kimura

Masaki Nakamura

Itaru Kimura

Hiroshi Nagura

Affiliations

Soon will be listed here.

Abstract

The immunohistochemical localization of nerve growth factor receptor (NGFR)-high-affinity NGFR (trk A) and low-affinity NGFR (LNGFR)-was investigated in 23 neuroblastoma group tumors, 18 pheochromocytomas, 2 mixed neuroendocrine-neural tumors, and 16 retinoblastomas. trk A was expressed in the tumor cells of all neuroblastomas, pheochromocytomas, and retinoblastomas. Immunoreactive intensity was especially strong in the larger ganglionic tumor cells of ganglioneuroblastoma and ganglioneuroma. Messenger RNA (mRNA) of trk A was also strongly expressed in the ganglionic cells of ganglioneuroblastomas and chromaffin cells of pheochromocytomas by in situ hybridization method. LNGFR was negative in the tumor cells of neuroblastoma; however, it showed strong immunoreactivity in ganglionic tumor cells and Schwann cells of ganglioneuroblastoma/ganglioneuroma, and sustentacular cells of pheochromocytoma. Although normal retina expressed both trk A and LNG FR, tumor cells of retinoblastoma were positive for only trk A but negative for LNGFR. Such differences in the expression of trk A and LNGFR may reflect neuronglial interactions in the survival and maturation of the sympathetic nerves, retina, and tumors in these tissues.

References

Chesa P, Rettig W, Thomson T, Old L, Melamed M . Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem. 1988; 36(4):383-9. DOI: 10.1177/36.4.2831267. View

Kimura N, Ishikawa T, Sasaki Y, Sasano N, Onodera K, Shimizu Y . Expression of prohormone convertase, PC2, in adrenocorticotropin-producing thymic carcinoid with elevated plasma corticotropin-releasing hormone. J Clin Endocrinol Metab. 1996; 81(1):390-5. DOI: 10.1210/jcem.81.1.8550783. View

Perosio P, Brooks J . Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors. Am J Pathol. 1988; 132(1):152-60. PMC: 1880630. View

Thoenen H, Barde Y . Physiology of nerve growth factor. Physiol Rev. 1980; 60(4):1284-335. DOI: 10.1152/physrev.1980.60.4.1284. View

Kaplan D, Hempstead B, Chao M, Parada L . The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 1991; 252(5005):554-8. DOI: 10.1126/science.1850549. View

Donovan M, Hempstead B, Horvath C, Chao M, Schofield D . Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors. Am J Pathol. 1993; 143(6):1560-7. PMC: 1887259. View

Ip N, Stitt T, Tapley P, Klein R, Glass D, Fandl J . Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron. 1993; 10(2):137-49. DOI: 10.1016/0896-6273(93)90306-c. View

Schachner M . Cell surface recognition and neuron-glia interactions. Ann N Y Acad Sci. 1991; 633:105-12. DOI: 10.1111/j.1749-6632.1991.tb15601.x. View

Baker D, Molenaar W, Trojanowski J, Evans A, Ross A, RORKE L . Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland. Am J Pathol. 1991; 139(1):115-22. PMC: 1886135. View

10.

Nakagawara A, Arima M, Azar C, Scavarda N, Brodeur G . Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res. 1992; 52(5):1364-8. View

11.

Donoso L, Shields C, Lee E . Immunohistochemistry of retinoblastoma. A review. Ophthalmic Paediatr Genet. 1989; 10(1):3-32. DOI: 10.3109/13816818909083770. View

12.

Hoshi N, HIRAKI H, Yamaki T, Natsume T, Watanabe K, Suzuki T . Frequent expression of 75 kDa nerve growth factor receptor and phosphotyrosine in human peripheral nerve tumours: an immunohistochemical study on paraffin-embedded tissues. Virchows Arch. 1994; 424(5):563-8. DOI: 10.1007/BF00191444. View

13.

Hempstead B, Kaplan D, Parada L, Chao M . High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 1991; 350(6320):678-83. DOI: 10.1038/350678a0. View

14.

Johnson D, Lanahan A, Buck C, Sehgal A, Morgan C, Mercer E . Expression and structure of the human NGF receptor. Cell. 1986; 47(4):545-54. DOI: 10.1016/0092-8674(86)90619-7. View

15.

Kogner P, Barbany G, Dominici C, Castello M, Raschella G, Persson H . Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 1993; 53(9):2044-50. View

16.

Kimura N, Togo A, Sugimoto T, Nata K, Okamoto H, Nagatsu I . Deficiency of Phenylethanolamine N-Methyltransferase in Norepinephrine-Producing Pheochromocytoma. Endocr Pathol. 1996; 7(2):131-136. DOI: 10.1007/BF02739972. View

17.

Chao M . Neurotrophin receptors: a window into neuronal differentiation. Neuron. 1992; 9(4):583-93. DOI: 10.1016/0896-6273(92)90023-7. View

18.

Goedert M, Otten U, Hunt S, Bond A, Chapman D, Schlumpf M . Biochemical and anatomical effects of antibodies against nerve growth factor on developing rat sensory ganglia. Proc Natl Acad Sci U S A. 1984; 81(5):1580-4. PMC: 344881. DOI: 10.1073/pnas.81.5.1580. View

19.

Hoehner J, Olsen L, Sandstedt B, Kaplan D, Pahlman S . Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am J Pathol. 1995; 147(1):102-13. PMC: 1869894. View

20.

Bothwell M . Tissue localization of nerve growth factor and nerve growth factor receptors. Curr Top Microbiol Immunol. 1991; 165:55-70. DOI: 10.1007/978-3-642-75747-1_4. View